Iovance Biotherapeutics, Inc.
$3.69B- Market cap
- $3.98B
- Debt
- +$1.00M
- Cash
- −$296.98M
Capital structure 100% equity / 0% debt · EV / Revenue 13.99x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: IOVA stock price vs NOMD: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NOMD's multiple
Needs NOMD P/S.
Implied fair value · at IOVA's multiple
Needs Revenue / share.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: IOVA FY 2025 (ended Dec 31, 2025) · NOMD FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 13.99x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
IOVANCE BIOTHERAPEUTICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Nomad Foods Limited · implied price per share
The ordinary-share to listed-security ratio could not be verified.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.00x
—
Net debt / EBITDA
Leverage against operating earnings
0.83x
—
Cash and equivalents
Liquid reserves on the balance sheet
$296.98M
—
Total debt
Interest-bearing obligations outstanding
$1.00M
$3.58B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BioNTech SE
IOVA vs BNTX
Moderna, Inc.
IOVA vs MRNA
GILEAD SCIENCES, INC.
IOVA vs GILD
Legend Biotech Corp
IOVA vs LEGN
MCCORMICK & CO INC
IOVA vs MKC
TYSON FOODS, INC.
IOVA vs TSN
Post Holdings, Inc.
IOVA vs POST
Kraft Heinz Co
IOVA vs KHC
GENERAL MILLS INC
IOVA vs GIS
HORMEL FOODS CORP /DE/
IOVA vs HRL
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.